+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
531210 COLINZ

Colinz Laboratories Share Price

 

 

Colinz Laboratories live price: ₹75.55. It opened at ₹76 vs previous close ₹72; intraday high/low: ₹76/₹76. The 50 & 200 DMA stand at ₹54.09/₹50.25.

Colinz Laboratories Performance

  • Today's Low
  • ₹76
  • Today's High
  • ₹76
  • 52 Week Low
  • ₹36
  • 52 Week High
  • ₹88
  • Open Price₹76
  • Previous Close₹72
  • Volume1,836
  • 50 DMA₹54.09
  • 100 DMA₹51.51
  • 200 DMA₹50.25

Colinz Laboratories Chart

Investment Returns

  • Over 1 Month + 71.7%
  • Over 3 Month + 73.76%
  • Over 6 Month + 59.05%
  • Over 1 Year + 56.81%

Smart Investing Starts Here Start SIP with Colinz Laboratories for Steady Growth!

Invest Now

Colinz Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 37
  • PEG Ratio
  • 10.3
  • Market Cap Cr
  • 19
  • P/B Ratio
  • 1.9
  • Average True Range
  • 3.35
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.27
  • RSI
  • 75.96
  • MFI
  • 66.91

Colinz Laboratories Financials

Colinz Laboratories Technicals

EMA & SMA

Current Price
₹75.55
+ 3.59 (4.99%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹59.20
  • 50 Day
  • ₹54.10
  • 100 Day
  • ₹51.50
  • 200 Day
  • ₹50.20

Resistance and Support

71.96 Pivot Speed
  • R3 71.96
  • R2 71.96
  • R1 71.96
  • S1 71.96
  • S2 71.96
  • S3 71.96

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Colinz Laboratories has an operating revenue of Rs. 6.14 Cr. on a trailing 12-month basis. An annual revenue de-growth of -3% needs improvement, Pre-tax margin of 11% is healthy, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 93 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 49 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Colinz Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-04-29 Quarterly Results
2026-01-24 Quarterly Results
2026-01-17 Others
2025-11-27 Others Inter-alia to approve appointment of Ms. Falguni Kumawat as the Company Secretary and Compliance Officer of the Company and Key Managerial Personnel of the Company.
2025-11-11 Others Inter-alia, to approve appointment of Smt. Vijaya Mani (DIN 11363910) as Additional (Non- Executive) Director of the Company.

Colinz Laboratories Shareholding Pattern

66%
31.22%
2.78%

Colinz Laboratories FAQs

Colinz Laboratories share price is ₹75 As on 25 June, 2026 | 09:42

The Market Cap of Colinz Laboratories is ₹19 Cr As on 25 June, 2026 | 09:42

The P/E ratio of Colinz Laboratories is 37 As on 25 June, 2026 | 09:42

The PB ratio of Colinz Laboratories is 1.9 As on 25 June, 2026 | 09:42

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23